Upgrade to SI Premium - Free Trial

B.Riley Downgrades Centessa Pharmaceuticals (CNTA) to Neutral

March 31, 2026 9:32 AM
B.Riley analyst Mayank Mamtani downgraded Centessa Pharmaceuticals (NASDAQ: CNTA) from ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Downgrades